伴有肝静脉和下腔静脉侵犯的肝细胞癌
Hepatocellular Carcinoma with Hepatic Vein and Inferior Vena Cava Invasion.
作者信息
Shukla Akash, Jain Abhinav
机构信息
Department of Gastroenterology, G.S.Medical College and KEM Hospital, Mumbai, India.
Gastro1 Hospital, Ahmedabad, India.
出版信息
J Clin Exp Hepatol. 2023 Sep-Oct;13(5):813-819. doi: 10.1016/j.jceh.2023.03.006. Epub 2023 Mar 28.
Abstract
Hepatocellular carcinoma (HCC) invades intrahepatic vessels causing tumor thrombosis. Infrequently, there is involvement of the hepatic vein (HV) and inferior vena cava (IVC). In this review, we summarize the epidemiology, classification, clinical features, and management of HCC with HV and IVC invasion. While the involvement of HV and IVC usually portends an overall poor survival, selected patients may be candidates for aggressive treatment and thus improving outcomes.
摘要
肝细胞癌（HCC）侵犯肝内血管可导致肿瘤血栓形成。肝静脉（HV）和下腔静脉（IVC）受累的情况较为少见。在本综述中，我们总结了伴有HV和IVC侵犯的HCC的流行病学、分类、临床特征及治疗方法。虽然HV和IVC受累通常预示总体生存率较差，但部分患者可能适合积极治疗从而改善预后。
相似文献
1
Hepatocellular Carcinoma with Hepatic Vein and Inferior Vena Cava Invasion.伴有肝静脉和下腔静脉侵犯的肝细胞癌
J Clin Exp Hepatol. 2023 Sep-Oct;13(5):813-819. doi: 10.1016/j.jceh.2023.03.006. Epub 2023 Mar 28.
2
A prediction model for overall survival after transarterial chemoembolization for hepatocellular carcinoma invading the hepatic vein or inferior vena cava.经肝动脉化疗栓塞治疗侵犯肝静脉或下腔静脉的肝细胞癌患者总生存期的预测模型。
Eur Radiol. 2021 Jun;31(6):4232-4242. doi: 10.1007/s00330-020-07536-8. Epub 2020 Nov 26.
3
Combined Chemoembolization and Radiotherapy Versus Chemoembolization Alone for Hepatocellular Carcinoma Invading the Hepatic Vein or Inferior Vena Cava.联合化疗栓塞和放疗与单纯化疗栓塞治疗侵犯肝静脉或下腔静脉的肝细胞癌。
Cardiovasc Intervent Radiol. 2021 Jul;44(7):1060-1069. doi: 10.1007/s00270-021-02815-3. Epub 2021 Mar 21.
4
Treatment outcomes of transcatheter arterial chemoembolization for hepatocellular carcinoma that invades hepatic vein or inferior vena cava.经导管动脉化疗栓塞术治疗侵犯肝静脉或下腔静脉的肝细胞癌的疗效
Cardiovasc Intervent Radiol. 2014 Dec;37(6):1507-15. doi: 10.1007/s00270-014-0841-1. Epub 2014 Jan 25.
5
Unusual Techniques for Preserving Surgical and Oncologic Safety in Hepatectomy of Advanced Adrenal Malignancy with Vena Cava and Liver Invasion.在伴有腔静脉和肝脏侵犯的晚期肾上腺恶性肿瘤肝切除术中，采用不同寻常的技术来保证手术和肿瘤学安全性。
Ann Surg Oncol. 2018 Oct;25(11):3324-3325. doi: 10.1245/s10434-018-6657-5. Epub 2018 Jul 17.
6
Long-term survival after anterior approach right hepatectomy combined with inferior vena cava thrombectomy using trans-diaphragmatic intrapericardial inferior vena cava occlusion: a case report and review of the literature.经膈肌心包内下腔静脉阻断行前入路右肝切除术联合下腔静脉血栓切除术的长期生存：一例报告并文献复习
BMC Surg. 2019 Aug 28;19(1):122. doi: 10.1186/s12893-019-0568-7.
7
Chemoembolization for Hepatocellular Carcinoma in Patients With Inferior Vena Caval/Right Atrial Tumor Thrombi Without Hepatic Vein Invasion.肝静脉未受侵犯的下腔静脉/右心房肿瘤血栓患者肝细胞癌的化疗栓塞术
Anticancer Res. 2021 Oct;41(10):5241-5247. doi: 10.21873/anticanres.15343.
8
Treatment outcomes of surgical resection for hepatocellular carcinoma with inferior vena cava invasion and/or thrombosis.伴有下腔静脉侵犯和/或血栓形成的肝细胞癌手术切除的治疗结果
Hepatogastroenterology. 2011 Sep-Oct;58(110-111):1694-9. doi: 10.5754/hge10653. Epub 2011 Jul 15.
9
Recurrence-free survival of a hepatocellular carcinoma patient with tumor thrombosis of the inferior vena cava after treatment with sorafenib and hepatic resection.索拉非尼联合肝切除术后下腔静脉肿瘤血栓形成的肝细胞癌患者的无复发生存期
Int Surg. 2015 May;100(5):908-14. doi: 10.9738/INTSURG-D-14-00133.1.
10
Resection of recurrent hepatocellular carcinoma with thrombi in the inferior vena cava, right atrium, and phrenic vein: a report of three cases.复发性肝细胞癌合并下腔静脉、右心房和膈静脉血栓切除术：三例报告。
World J Surg Oncol. 2020 Jun 22;18(1):138. doi: 10.1186/s12957-020-01914-8.
引用本文的文献
1
Clinical Comparison Between Curative and Non-Curative Treatment for Hepatocellular Carcinoma with Hepatic Vein Invasion: A Nationwide Cohort Study.肝细胞癌伴肝静脉侵犯的根治性与非根治性治疗的临床比较：一项全国性队列研究
Cancers (Basel). 2025 May 27;17(11):1794. doi: 10.3390/cancers17111794.
2
Case Report: Multidisciplinary discussion and management of a case involving a non-seminomatous germ cell tumor complicated by the presence of cancerous thrombus in the inferior vena cava.病例报告：1例非精原细胞瘤性生殖细胞肿瘤合并下腔静脉癌栓病例的多学科讨论与管理
Front Oncol. 2025 Apr 16;15:1532983. doi: 10.3389/fonc.2025.1532983. eCollection 2025.
3
Managing Complex Hepatocellular Carcinoma Subtypes: Diffuse Infiltrative, Large Tumours, and Tumour Rupture-The Challenges and Strategies.复杂肝细胞癌亚型的管理：弥漫浸润型、大肿瘤及肿瘤破裂——挑战与策略
J Clin Exp Hepatol. 2025 May-Jun;15(3):102505. doi: 10.1016/j.jceh.2025.102505. Epub 2025 Jan 22.
4
Multimodal transesophageal echocardiography in the surgical resection of patients with hepatocellular carcinoma and inferior vena cava tumor thrombus.多模态经食管超声心动图在肝细胞癌合并下腔静脉瘤栓患者手术切除中的应用
J Gastrointest Oncol. 2024 Dec 31;15(6):2588-2598. doi: 10.21037/jgo-24-731. Epub 2024 Dec 27.
5
Case report: Combination therapy for hepatocellular carcinoma with inferior vena cava or right atrial tumor thrombus in the era of combined targeted and immunotherapeutic agents.病例报告：在联合靶向和免疫治疗药物时代，肝细胞癌合并下腔静脉或右心房肿瘤血栓的联合治疗
Front Oncol. 2024 Dec 11;14:1470374. doi: 10.3389/fonc.2024.1470374. eCollection 2024.
本文引用的文献
1
Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL).布加综合征：亚太肝病学会（APASL）的共识指南。
Hepatol Int. 2021 Jun;15(3):531-567. doi: 10.1007/s12072-021-10189-4. Epub 2021 Jul 8.
2
Hepatic vein tumor thrombosis in patients with hepatocellular carcinoma: Prevalence and clinical significance.肝细胞癌患者肝静脉肿瘤血栓：发生率和临床意义。
United European Gastroenterol J. 2021 Jun;9(5):590-597. doi: 10.1002/ueg2.12098. Epub 2021 Jun 2.
3
Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis.伴有大血管肿瘤血栓形成的晚期肝细胞癌患者接受免疫检查点抑制剂治疗的真实世界结局。
Cancer Immunol Immunother. 2021 Jul;70(7):1929-1937. doi: 10.1007/s00262-020-02845-9. Epub 2021 Jan 6.
4
A new classification for hepatocellular carcinoma with hepatic vein tumor thrombus.伴有肝静脉瘤栓的肝细胞癌的新分类
Hepatobiliary Surg Nutr. 2020 Dec;9(6):717-728. doi: 10.21037/hbsn.2019.10.07.
5
Report of the 20th Nationwide follow-up survey of primary liver cancer in Japan.日本第20次全国原发性肝癌随访调查结果报告。
Hepatol Res. 2020 Jan;50(1):15-46. doi: 10.1111/hepr.13438. Epub 2020 Jan 5.
6
TFAP4 Promotes Hepatocellular Carcinoma Invasion and Metastasis via Activating the PI3K/AKT Signaling Pathway.TFAP4 通过激活 PI3K/AKT 信号通路促进肝癌侵袭和转移。
Dis Markers. 2019 Jun 10;2019:7129214. doi: 10.1155/2019/7129214. eCollection 2019.
7
Transcatheter arterial chemoembolization experience for advanced hepatocellular carcinoma with right atrial tumor thrombus.经导管动脉化疗栓塞术治疗伴有右心房瘤栓的晚期肝细胞癌的经验
J Cancer Res Ther. 2019;15(2):305-311. doi: 10.4103/jcrt.JCRT_923_17.
8
FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma.FAM134B 通过 Akt 信号通路诱导肝癌发生和上皮间质转化。
Mol Oncol. 2019 Apr;13(4):792-810. doi: 10.1002/1878-0261.12429. Epub 2019 Jan 24.
9
Two Nomograms to Select Hepatocellular Carcinoma Patients with Macroscopic Vascular Invasion for Hepatic Resection.用于选择伴有肉眼可见血管侵犯的肝细胞癌患者进行肝切除的两个列线图
J Cancer. 2018 Sep 7;9(18):3287-3294. doi: 10.7150/jca.25899. eCollection 2018.
10
Percutaneous thermal ablation combined with TACE versus TACE monotherapy in the treatment for liver cancer with hepatic vein tumor thrombus: A retrospective study.经皮热消融联合 TACE 与单纯 TACE 治疗合并肝静脉癌栓肝癌：一项回顾性研究。
PLoS One. 2018 Jul 31;13(7):e0201525. doi: 10.1371/journal.pone.0201525. eCollection 2018.
Zotero 插件